FTXH
First Trust Nasdaq Pharmaceuticals ETF
1 year +45.5%Every component of FTXH and its weight in the fund, as of 2026-10-23.
| Component | Weight | % | Sector |
|---|---|---|---|
| ABBVAbbVie Inc · United States | 8.10% | Healthcare | |
| LLYEli Lilly and Company · United States | 7.43% | Healthcare | |
| PFEPfizer Inc · United States | 7.40% | Healthcare | |
| MRKMerck & Company Inc · United States | 6.76% | Healthcare | |
| JNJJohnson & Johnson · United States | 6.49% | Healthcare | |
| VTRSViatris Inc · United States | 4.05% | Healthcare | |
| BIIBBiogen Inc · United States | 3.88% | Healthcare | |
| GILDGilead Sciences Inc · United States | 3.75% | Healthcare | |
| AMGNAmgen Inc · United States | 3.69% | Healthcare | |
| REGNRegeneron Pharmaceuticals Inc · United States | 3.64% | Healthcare | |
| ZTSZoetis Inc · United States | 3.48% | Healthcare | |
| UTHRUnited Therapeutics Corporation · United States | 3.23% | Healthcare | |
| INCYIncyte Corporation · United States | 3.21% | Healthcare | |
| VRTXVertex Pharmaceuticals Inc · United States | 3.21% | Healthcare | |
| BMYBristol-Myers Squibb Company · United States | 3.07% | Healthcare | |
| EXELExelixis Inc · United States | 2.37% | Healthcare | |
| JAZZJazz Pharmaceuticals PLC · United States | 2.36% | Healthcare | |
| ILMNIllumina Inc · United States | 2.10% | Healthcare | |
| HALOHalozyme Therapeutics Inc · United States | 1.76% | Healthcare | |
| MEDPMedpace Holdings Inc · United States | 1.49% | Healthcare | |
| NBIXNeurocrine Biosciences Inc · United States | 1.22% | Healthcare | |
| BMRNBiomarin Pharmaceutical Inc · United States | 1.14% | Healthcare | |
| ALNYAlnylam Pharmaceuticals Inc · United States | 1.14% | Healthcare | |
| ELANElanco Animal Health · United States | 1.13% | Healthcare | |
| CRLCharles River Laboratories · United States | 1.10% | Healthcare | |
| IOVAIovance Biotherapeutics Inc · United States | 0.92% | Healthcare | |
| MRNAModerna Inc · United States | 0.84% | Healthcare | |
| CAICaris Life Sciences, Inc. Common Stock · United States | 0.61% | Healthcare | |
| BCTGBCTG Acquisition Corp · United States | 0.55% | Financial Services | |
| TXG10X Genomics Inc · United States | 0.55% | Healthcare | |
| LGNDLigand Pharmaceuticals Incorporated · United States | 0.54% | Healthcare | |
| AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock · United States | 0.54% | Healthcare | |
| TWSTTwist Bioscience Corp · United States | 0.51% | Healthcare | |
| CORTCorcept Therapeutics Incorporated · United States | 0.51% | Healthcare | |
| ROIVRoivant Sciences Ltd · United States | 0.50% | Healthcare | |
| TGTXTG Therapeutics Inc · United States | 0.49% | Healthcare | |
| SYRESpyre Therapeutics Inc. · United States | 0.49% | Healthcare | |
| GHGuardant Health Inc · United States | 0.49% | Healthcare | |
| ADPTAdaptive Biotechnologies Corp · United States | 0.47% | Healthcare | |
| PTGXProtagonist Therapeutics Inc · United States | 0.45% | Healthcare | |
| KYMRKymera Therapeutics Inc · United States | 0.44% | Healthcare | |
| ALKSAlkermes Plc · United States | 0.44% | Healthcare | |
| KRYSKrystal Biotech Inc · United States | 0.42% | Healthcare | |
| ORKAOruka Therapeutics, Inc. · United States | 0.41% | Healthcare | |
| TVTXTravere Therapeutics Inc · United States | 0.39% | Healthcare | |
| DNTHDianthus Therapeutics Inc. · United States | 0.36% | Healthcare | |
| ELVNEnliven Therapeutics Inc. · United States | 0.34% | Healthcare | |
| ARWRArrowhead Pharmaceuticals Inc · United States | 0.33% | Healthcare | |
| ACADACADIA Pharmaceuticals Inc · United States | 0.33% | Healthcare | |
| LQDALiquidia Technologies Inc · United States | 0.27% | Healthcare |
From the market data provider's fund data, read 2026-10-23. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.